Butantan Institute
Clinical trials sponsored by Butantan Institute, explained in plain language.
-
New dengue vaccine shows promise in Head-to-Head trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new dengue vaccine called V181 against an existing vaccine (Butantan-DV) in 1,364 healthy adults aged 18-50 in Brazil. The goal was to see if V181 is as safe and triggers a similar immune response. Results will help decide if V181 can be used to protect agains…
Phase: PHASE2 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:06 UTC
-
New quad flu shot for babies shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new quadrivalent influenza vaccine (protecting against four flu strains) in over 1,300 healthy infants and children aged 6 to 35 months. The goal was to see if the vaccine triggers a strong immune response and is safe compared to existing flu vaccines. Results…
Phase: PHASE3 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:01 UTC
-
Brazilian flu vaccine shows promise in Head-to-Head trial
⭐️ VACCINE ⭐️ CompletedThis study tested whether a new seasonal flu vaccine made by Butantan Institute works as well and is as safe as a standard Sanofi vaccine. 632 healthy adults in Brazil received one of the two shots. Researchers measured immune response and tracked side effects like pain, fever, a…
Phase: PHASE4 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:03 UTC